LAVA Therapeutics NV
LVTX
$1.68
Closing
▼-4.00%
1D
▲6.33%
YTD
LVTX
BBG00L04L554
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$44.17M
Analysts' Rating
STRONG BUY
Price Target (Mean)
7.25
Total Analysts
2
P/E
Operating Margin
0.00%
Beta
0.48
Revenue Growth
-100.00%
52 week high
$6.45
52 week low
$1.44
Div. Yield
%
EPS Growth
1450.00
Company Profile
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
